Merck KGaA
MKGAF
$129.45
-$4.45-3.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.11B | 6.22B | 5.96B | 5.56B | 5.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.11B | 6.22B | 5.96B | 5.56B | 5.78B |
| Cost of Revenue | 2.57B | 2.46B | 2.53B | 2.25B | 2.43B |
| Gross Profit | 3.54B | 3.76B | 3.44B | 3.31B | 3.35B |
| SG&A Expenses | 1.79B | 1.71B | 1.68B | 1.54B | 1.59B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -58.20M | -149.65M | 137.33M | 126.28M | -277.15M |
| Total Operating Expenses | 5.03B | 4.79B | 4.95B | 4.50B | 4.29B |
| Operating Income | 1.08B | 1.43B | 1.01B | 1.06B | 1.48B |
| Income Before Tax | 466.80M | 1.31B | 940.86M | 1.01B | 863.43M |
| Income Tax Expenses | 89.64M | 263.05M | 197.48M | 229.41M | 149.24M |
| Earnings from Continuing Operations | 377.17M | 1.05B | 743.38M | 776.63M | 714.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.82M | 4.68M | -3.40M | -3.16M | -3.20M |
| Net Income | 371.35M | 1.05B | 739.97M | 773.47M | 711.00M |
| EBIT | 1.08B | 1.43B | 1.01B | 1.06B | 1.48B |
| EBITDA | 1.52B | 1.96B | 1.50B | 1.56B | 1.60B |
| EPS Basic | 0.85 | 2.42 | 1.70 | 1.78 | 1.64 |
| Normalized Basic EPS | 1.83 | 1.89 | 1.35 | 1.44 | 2.25 |
| EPS Diluted | 0.85 | 2.42 | 1.70 | 1.78 | 1.64 |
| Normalized Diluted EPS | 1.83 | 1.89 | 1.35 | 1.44 | 2.25 |
| Average Basic Shares Outstanding | 434.80M | 435.75M | 434.67M | 434.91M | 434.80M |
| Average Diluted Shares Outstanding | 434.80M | 435.75M | 434.67M | 434.91M | 434.80M |
| Dividend Per Share | 2.56 | -- | -- | -- | 2.35 |
| Payout Ratio | 0.00% | -- | 152.30% | 6.26% | 0.00% |